Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease.
Müller-Ladner U, Dignass A, Gaffney K, Jadon D, Matucci-Cerinic M, Lobaton T, Carron P, Gisbert JP, Pande I, Utzinger M, Addison J. Müller-Ladner U, et al. Among authors: gisbert jp. BioDrugs. 2023 Nov;37(6):873-889. doi: 10.1007/s40259-023-00616-3. Epub 2023 Aug 26. BioDrugs. 2023. PMID: 37632666 Free PMC article. Clinical Trial.
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.
Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S; European Crohn’s and Colitis Organisation [ECCO]. Dignass AU, et al. Among authors: gisbert jp. J Crohns Colitis. 2015 Mar;9(3):211-22. doi: 10.1093/ecco-jcc/jju009. Epub 2014 Dec 3. J Crohns Colitis. 2015. PMID: 25518052 No abstract available.
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.
Dragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F; “TOFA-poSTOP” Study Group. Dragoni G, et al. Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002676. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38305302
Headache in patients with inflammatory bowel disease: Migraine prevalence according to the Migraine Screening-Questionnaire (MS-Q) and headache characteristics.
Gonzalez-Martinez A, Muro I, Quintas S, Chaparro M, Gisbert JP, Sanz-García A, Casanova MJ, Rubín de Célix C, Vivancos J, Gago-Veiga AB. Gonzalez-Martinez A, et al. Among authors: gisbert jp. Gastroenterol Hepatol. 2024 Jan;47(1):63-71. doi: 10.1016/j.gastrohep.2023.05.001. Epub 2023 May 5. Gastroenterol Hepatol. 2024. PMID: 37149259 English, Spanish.
Sexually transmitted infections as a differential diagnosis of inflammatory bowel disease.
Martínez Benito B, Gisbert JP, García Fraile Fraile LJ, Barrios Blandino A, Chaparro M. Martínez Benito B, et al. Among authors: gisbert jp. Gastroenterol Hepatol. 2024 Feb;47(2):182-183. doi: 10.1016/j.gastrohep.2023.05.003. Epub 2023 May 5. Gastroenterol Hepatol. 2024. PMID: 37150250 English, Spanish. No abstract available.
FiLaC® procedure for highly selected anal fistula patients: indications, safety and efficacy from an observational study at a tertiary referral center.
Blanco Terés L, Bermejo Marcos E, Cerdán Santacruz C, Correa Bonito A, Rodríguez Sanchez A, Chaparro M, Gisbert JP, García Septiem J, Martín-Pérez E. Blanco Terés L, et al. Among authors: gisbert jp. Rev Esp Enferm Dig. 2023 Dec;115(12):700-706. doi: 10.17235/reed.2023.9644/2023. Rev Esp Enferm Dig. 2023. PMID: 37449475 Free article.
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients.
Aldars-García L, Gil-Redondo R, Embade N, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, Fernández-Salazar L, Ceballos D, Manuel Benítez J, Aguas M, Baston-Rey I, Bermejo F, José Casanova M, Lorente R, Ber Y, Ginard D, Esteve M, de Francisco R, José García M, Francés R, Rodríguez Pescador A, Velayos B, Del Río EG, Marín Pedrosa S, Minguez Sabater A, Barreiro-de Acosta M, Algaba A, Verdejo Gil C, Rivas O, Royo V, Aceituno M, Garre A, Baldán-Martín M, Ramírez C, Sanz-García A, Lozano JJ, Sidorova J, Millet O, Bernardo D, Gisbert JP, Chaparro M. Aldars-García L, et al. Among authors: gisbert jp. Inflamm Bowel Dis. 2024 Feb 1;30(2):167-182. doi: 10.1093/ibd/izad154. Inflamm Bowel Dis. 2024. PMID: 37536268
IMPACT OF MESALAZINE ON THE RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTRE STUDY OF GETECCU (VACOVEII STUDY).
Deza DC, Julián Gomara AB, Biota EC, Beltrán B, Domènech E, Casbas AG, Mañosa M, Zabana Y, Alfaro LR, Romero EV, González EG, Sicilia B, Laredo V, Alcalá Escriche MJ, Velázquez LM, Iglesias RF, Pérez AP, Calafat M, Iturria SR, Yudego IM, Nieto YB, Mateo SG, Gisbert JP, Lidón RV, Arias L, Alfambra E, Roche PC, de Acosta MB, López SG. Deza DC, et al. Among authors: gisbert jp. Gastroenterol Hepatol. 2024 Jan 12:S0210-5705(24)00017-7. doi: 10.1016/j.gastrohep.2023.12.012. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
889 results